NEBION AG

Nebion is an ETH spin-off company founded in Zurich in 2008 with the mission to support researchers in biology and medicine. In July 2021, Nebion was acquired by Immunai. Nebion continues to operate under that name and has become a wholly owned subsidiary of Immunai, with offices in Zurich and Prague.

Immunai was founded in December 2018 and has over 120 employees in 5 offices - New York (HQ), San Francisco, Tel-Aviv, Zurich and Prague. We are a multidisciplinary team of immunologists, genomics technologists, computer scientists, engineers, mathematicians and operators singularly focused on comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.